Company Filing History:
1 out of 1 
1 out of 5,463 
1 out of 832,912 Years Active: 1991-1994
Title: The Innovations of Per H Langsjoen
Introduction
Per H Langsjoen is a notable inventor based in Temple, TX (US). He has made significant contributions to the field of biomedical research, particularly in the area of cardiovascular health. With a total of 3 patents, Langsjoen's work focuses on improving patient outcomes through innovative treatments.
Latest Patents
Langsjoen's latest patents include groundbreaking methods for using coenzyme Q.sub.10 in combination with HMG-CoA reductase inhibitors. One of his notable inventions discloses methods for inhibiting the side effects associated with HMG-CoA reductase inhibitors. This treatment not only reduces cholesterol levels but also protects against typical side effects such as liver and cardiac dysfunction. The combination of lovastatin, an HMG-CoA reductase inhibitor, and coenzyme Q.sub.10 in specific ratios has shown significant enhancement of a patient's cardiac condition. Additionally, he has developed a formulation to ameliorate the reductions of coenzyme Q.sub.10 in cardiomyopathy, addressing the serious side effects of mevinolin that depress body levels of coenzyme Q.sub.10 and cardiac function.
Career Highlights
Throughout his career, Langsjoen has worked with various organizations, including the Karl Folkers Foundation for Biomedical and Clinical Research. His research has been pivotal in advancing the understanding of cardiovascular treatments and improving patient care.
Collaborations
Langsjoen has collaborated with notable individuals in the field, including Karl A Folkers and Richard A Willis. These partnerships have contributed to the success of his research and innovations.
Conclusion
Per H Langsjoen's contributions to biomedical research and his innovative patents have made a significant impact on cardiovascular health. His work continues to influence the field and improve patient outcomes.